This page is not the official website. Generated by AI, does not constitute any advice. If needed, please click here to visit the corresponding official website.
Xi'an Wanlong Pharmaceutical Co., Ltd – a GMP & DMF-compliant modern pharmaceutical enterprise established in 1995. Specializing in Active Pharmaceutical Ingredients, Finished Dosage Forms, and Intermediates for global markets.
Xi'an Wanlong Pharmaceutical Co., Ltd was founded in 1995 and is a comprehensive modern pharmaceutical enterprise. We specialize in the production of formulations, Active Pharmaceutical Ingredients (API), and chemical intermediates. Our facilities are fully compliant with GMP standards, and we maintain active DMF filings for key products.
With a registered capital of CNY 75 million and a facility spanning over 2,000,000 square meters, we are equipped to meet the growing demands of international pharmaceutical partners. All our workshops adhere strictly to GMP requirements, ensuring product quality and regulatory compliance.
High-purity Active Pharmaceutical Ingredients and Finished Dosage Forms manufactured under strict GMP standards. All products are supported by comprehensive documentation including DMF files.
High molecular weight polysaccharide used in plasma expanders and chromatography.
Pharmaceutical-grade organic acid used in infusion solutions and dietary supplements.
Potent antiplatelet agent used in acute coronary syndrome treatment.
Dipeptide used in parenteral nutrition for critical care patients.
Second-generation antihistamine used in allergy medications.
Third-generation cephalosporin antibiotic for bacterial infections.
Broad-spectrum fluoroquinolone antibiotic with high bioavailability.
DPP-4 inhibitor used in type 2 diabetes management.
From R&D to large-scale manufacturing, we offer end-to-end pharmaceutical solutions with full regulatory compliance.
Advanced research and development of new APIs and formulations. Our team focuses on process optimization, impurity profiling, and scalable synthesis.
State-of-the-art facilities covering over 2 million square meters. All production lines are GMP-compliant with strict quality control protocols.
Full regulatory support with active DMF filings for key products. We provide comprehensive documentation for global regulatory submissions.
Stay updated with the latest developments, certifications, and industry insights from Xi'an Wanlong.
Our latest production line for cardiovascular APIs has received full GMP certification, enhancing capacity and quality assurance.
We have submitted a new Drug Master File for injectable-grade L-Alanyl-L-Glutamine to support global regulatory submissions.
Xi'an Wanlong has entered a joint development agreement with a European partner for next-generation antidiabetic compounds.
For inquiries about our APIs, FDFs, or partnership opportunities, please reach out through our official channels.
Notice for Buyers: If you are a buyer, the above information is generated by AI collection and does not constitute any advice. If necessary, please visit the corresponding official website.
For Domain Owners: If you are the domain owner and do not want to be included by fobcompany.info, please contact [email protected] via your corporate email to cancel. We will cancel your inclusion within 3 business days.
如果您是域名所有者 不想被fobcompany.info收录 请用企业邮箱联系[email protected] 取消收录 我们将在3个工作日取消您的收录
Service Request: If you are other domain and want to be included, please contact [email protected]
如果您是其他域名合作 也请联系[email protected]